LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Lucid Diagnostics (NASDAQ: LUCD)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ LUCD Lucid Diagnostics
PALUMBO JOHN R / director
10/06/2025
Buy
$1.03
215,000
$221K
215,000